- JohanssonBE,MoranTM,KilbourneED.Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins.Proc Natl Acad Sci USA1987; 84:6869–6873.
- LaverWG,GerhardW,WebsterRGet al.Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies.Proc Natl Acad Sci USA1979; 76:1425–1429.
- MeiklejohnG,EickhoffTC,GravesPet al.Antigenic drift and efficacy of influenza virus vaccines, 1976—1977.J Infect Dis1978; 138:618–624.
- LiuM,SongT,HuaSet al.Computational analysis of antigenic epitopes of avian influenza A (H7N9) viruses.Sci China Life Sci2015; 58:687–693.
- Alvarado-FacundoE,VassellR,SchmeisserFet al.Glycosylation of residue 141 of subtype H7 influenza a hemagglutinin (HA) affects HA-pseudovirus infectivity and sensitivity to site a neutralizing antibodies.PLoS One2016; 11:e0149149.
- World Health OrganizationW. G. I. S. Manual for the laboratory diagnosis and virological surveillance of influenza.WHO: Geneva.2011.Available athttp://www.who.int/influenza/gisrs_laboratory/manual_diagnosis_surveillance_influenza/en/.
- ShiY,ZhangW,WangFet al.Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses.Science2013; 342:243–247.
- ZhuW,ZhuY,QinKet al.Mutations in polymerase genes enhanced the virulence of 2009 pandemic H1N1 influenza virus in mice.PLoS One2012; 7:e33383.
- ToKK,TsangAK,ChanJFet al.Emergence in China of human disease due to avian influenza A(H10N8)—cause for concern?J Infect2014; 68:205–215.
Open access
447
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editors
The S128N mutation combined with an additional potential N-linked glycosylation site at residue 133 in hemagglutinin affects the antigenicity of the human H7N9 virus
Wanli LiuThe Center for Disease Control and Prevention, Urumqi, Xinjiang Uygur Autonomous Region830001, China
, Tian BaiNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China
, Jinlei GuoNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China
, Xinlan LiThe Center for Disease Control and Prevention, Urumqi, Xinjiang Uygur Autonomous Region830001, China
, Lei YangNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China
, Xiaojun WangThe Center for Disease Control and Prevention, Urumqi, Xinjiang Uygur Autonomous Region830001, China
, Junfeng GuoNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China
, Xin MaThe Center for Disease Control and Prevention, Urumqi, Xinjiang Uygur Autonomous Region830001, China
, Xiyan LiNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China
, Hongbin LiuThe Center for Disease Control and Prevention, Urumqi, Xinjiang Uygur Autonomous Region830001, China
, Jianfang ZhouNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China
, Dayan WangNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, China
& Yue-Long ShuNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing102206, ChinaCorrespondence[email protected]
show all
Pages 1-2
|
Received 08 Jan 2016, Accepted 05 Apr 2016, Published online: 25 Jan 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.